産婦人科学(婦人科)

Medicine & Life Sciences

1. Endometrial Neoplasms 100%
2. Ovarian Neoplasms 62%
3. Uterine Cervical Neoplasms 60%
4. Japan 54%
5. Neoplasms 42%
6. Uterus 26%
7. Carcinoma 22%
8. Gynecology 21%
9. Obstetrics 20%
10. Ovarian Epithelial Carcinoma 19%
11. Clear Cell Adenocarcinoma 19%
12. Drug Therapy 18%
13. Transplantation 17%
14. Paclitaxel 17%
15. Therapeutics 16%
16. Cervical Intraepithelial Neoplasia 15%
17. Carboplatin 14%
18. Survival 14%
19. Uterine Neoplasms 13%
20. Genes 13%
21. Adenocarcinoma 13%
22. Neoplasm Metastasis 13%
23. Lymph Node Excision 12%
24. Hereditary Nonpolyposis Colorectal Neoplasms 12%
25. Macaca 12%
26. Cisplatin 11%
27. Trachelectomy 11%
28. Mutation 11%
29. DNA Mismatch Repair 11%
30. Platinum 11%
31. Lymph Nodes 11%
32. Endometrial Hyperplasia 11%
33. Cervix Uteri 10%
34. Microsatellite Instability 10%
35. Hysterectomy 9%
36. Primates 9%
37. Endometrium 9%
38. Cell Biology 9%
39. Galactosyltransferases 8%
40. Glycolipids 8%
41. Carcinogenesis 8%
42. Progression-Free Survival 8%
43. Retrospective Studies 8%
44. Cell Line 8%
45. Hysteroscopy 7%
46. Endometriosis 7%
47. Endometrioid Carcinoma 7%
48. Guidelines 7%
49. Biomarkers 7%
50. Salpingo-oophorectomy 7%
51. Drug Repositioning 7%
52. Irinotecan 7%
53. Medical Oncology 7%
54. Human papillomavirus 16 7%
55. Adjuvant Chemotherapy 7%
56. MicroRNAs 7%
57. Early Detection of Cancer 7%
58. Infertility 7%
59. Recurrence 6%
60. Pharmaceutical Preparations 6%
61. Safety 6%
62. Fertility 6%
63. Carcinosarcoma 6%
64. Bevacizumab 6%
65. Confidence Intervals 6%
66. Ovary 6%
67. Annual Reports 6%
68. DNA 6%
69. Proteins 6%
70. Pregnancy 6%
71. Multicenter Studies 6%
72. Genome 6%
73. Epigenomics 6%
74. Indocyanine Green 5%
75. Chemoradiotherapy 5%
76. Tumor Biomarkers 5%
77. Antigens 5%
78. Narrow Band Imaging 5%
79. Squamous Cell Carcinoma 5%
80. dienogest 5%
81. Germ-Line Mutation 5%
82. pembrolizumab 5%
83. Fertility Preservation 5%
84. Radiotherapy 5%
85. Breast Neoplasms 5%
86. Methylation 5%
87. Peutz-Jeghers Syndrome 5%
88. liposomal doxorubicin 5%
89. Carbohydrates 5%
90. Antibodies 5%
91. Macaca fascicularis 5%
92. Registries 5%